Cargando…
Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922576/ https://www.ncbi.nlm.nih.gov/pubmed/36792428 http://dx.doi.org/10.1016/j.ejim.2023.02.014 |
_version_ | 1784887562812260352 |
---|---|
author | Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Luna, Juan de Dios |
author_facet | Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Luna, Juan de Dios |
author_sort | Pardo-Cabello, Alfredo Jose |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9922576 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | European Federation of Internal Medicine. Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99225762023-02-13 Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Luna, Juan de Dios Eur J Intern Med Letter to the Editor European Federation of Internal Medicine. Published by Elsevier B.V. 2023-06 2023-02-13 /pmc/articles/PMC9922576/ /pubmed/36792428 http://dx.doi.org/10.1016/j.ejim.2023.02.014 Text en © 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Pardo-Cabello, Alfredo Jose Manzano-Gamero, Victoria Luna, Juan de Dios Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe |
title | Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe |
title_full | Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe |
title_fullStr | Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe |
title_full_unstemmed | Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe |
title_short | Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe |
title_sort | safety of covid-19 vaccines: a comparison between adverse drug reactions among vaccines marketed in europe |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922576/ https://www.ncbi.nlm.nih.gov/pubmed/36792428 http://dx.doi.org/10.1016/j.ejim.2023.02.014 |
work_keys_str_mv | AT pardocabelloalfredojose safetyofcovid19vaccinesacomparisonbetweenadversedrugreactionsamongvaccinesmarketedineurope AT manzanogamerovictoria safetyofcovid19vaccinesacomparisonbetweenadversedrugreactionsamongvaccinesmarketedineurope AT lunajuandedios safetyofcovid19vaccinesacomparisonbetweenadversedrugreactionsamongvaccinesmarketedineurope |